A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM
Clinical trial NCT03560973 · COMPLETED
Trial details
- NCT number
- NCT03560973
- Sponsor
- Gruppo Oncologico Italiano di Ricerca Clinica
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2018-07-30
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.